Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline in high-risk hematologic patients with febrile neutropenia
ChiCTR-OPC-15006934Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tigecycline in febrile neutropenia (FN), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Febrile episode resolution. Started Feb 2015; status: recruiting.
02
Drugs
tigecycline
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on ChiCTR-OPC-15006934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006934.